CD4 and Huntington disease: To evaluate the co-stimulatory capacity, the four different subsets of CD21low B cells and the respective CD21pos populations of patients with AI disorders and HD were co-cultured with allogenic CD4 T cells of third-party healthy individuals in the presence of SEB.